Jasper Therapeutics, Inc. (JSPR) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts JSPR Hot Sheet
Join SI Premium – FREE
Jasper Therapeutics, Inc. (NASDAQ: JSPR) reported Q1 EPS of ($0.16), in-line with the analyst estimate of ($0.16).
For earnings history and earnings-related data on Jasper Therapeutics, Inc. (JSPR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c
- L3Harris CEO steps down amid conduct review, shares drop
- The LGL Group (LGL) Misses Q2 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
